/

Batteries & E-Mobility

/

Minaris Regenerative Medicine

Minaris Regenerative Medicine

Minaris Regenerative Medicine

Verified Nov 2026

Batteries & E-Mobility

·

Japan flag

Tokyo, Tokyo

·

Since 2025

Minaris Regenerative Medicine, headquartered in Tokyo and founded in 2025, is a contract development and manufacturing organization with 500–1,000 employees serving automotive, electric-vehicle, medical, and industrial-equipment sectors. The company provides cell and gene therapy manufacturing, viral vector production, and biosafety testing services, drawing on over 25 years in cell therapy development and 40 years in analytical testing. Recent activity includes establishing a dedicated viral vectors business unit in September 2026.

Minaris Regenerative Medicine

Verified Nov 2026

AT A GLANCE

Founded

2025

Headquarters

Japan flag

Tokyo, Tokyo

Employees

500-1,000

Ownership

Minaris Regenerative Medicine at a glance

Employees

500-1,000

Founded

2025

Headquarters

Tokyo, Tokyo

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Overview

Minaris Regenerative Medicine, headquartered in Tokyo and founded in 2025, is a contract development and manufacturing organization with 500–1,000 employees serving automotive, electric-vehicle, medical, and industrial-equipment sectors. The company provides cell and gene therapy manufacturing, viral vector production, and biosafety testing services, drawing on over 25 years in cell therapy development and 40 years in analytical testing. Recent activity includes establishing a dedicated viral vectors business unit in September 2026.

At a glance

Attribute

Detail

Founded

2025

Headquarters

Tokyo, Tokyo

Employees

500-1,000

Primary capability

Batteries & E-Mobility

What Minaris Regenerative Medicine makes

Minaris offers GMP manufacturing, plasmid and vector design, viral clearance testing, cell banking, potency assays, stability studies, and characterization services for cell and gene therapies.

Products and capabilities described on the company's own site include LED (source: minaris.com).

Latest developments

Facilities

Minaris Regenerative Medicine is headquartered in Tokyo, Tokyo. Public sources also reference these locations:

Company details

The company operates facilities in the United States, Europe, and Asia, including sites in Philadelphia and Munich, supporting biotech firms, pharmaceutical companies, and academic researchers. Minaris Regenerative Medicine was founded in 2025, has an estimated 500-1,000 employees, and is headquartered in Tokyo, Tokyo.

Frequently asked questions

What does Minaris Regenerative Medicine make?

Minaris Regenerative Medicine, headquartered in Tokyo and founded in 2025, is a contract development and manufacturing organization with 500–1,000 employees serving automotive, electric-vehicle, medical, and industrial-equipment sectors. The company provides cell and gene therapy manufacturing, viral vector production, and biosafety testing services, drawing on over 25 years in cell therapy development and 40 years in analytical testing. Recent activity includes establishing a dedicated viral vectors business unit in September 2026.

Where is Minaris Regenerative Medicine headquartered?

Minaris Regenerative Medicine is headquartered in Tokyo, Tokyo.

When was Minaris Regenerative Medicine founded?

Minaris Regenerative Medicine was founded in 2025.

How big is Minaris Regenerative Medicine?

Minaris Regenerative Medicine has an estimated 500-1,000 employees.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Tokyo, Tokyo (HQ)Headquarters · Tokyo, Japan
Tokyo, Tokyo (HQ)Tokyo, Tokyo, JapanHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.